|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,684.00 DKK | -1.66% |
|
+2.59% | -16.92% |
| 12/05 | Nordea resumes coverage of Genmab with Buy rating and DKK 2,015 price target | FW |
| 11/05 | Deutsche Bank trims Genmab price target to DKK 2,250 (2,400), reiterates Buy | FW |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.66% | +2.59% | -8.43% | -11.58% | -16.92% | +30.04% | -41.59% | -24.52% | +66.90% | 1.61TCr | |
| -0.14% | +3.34% | -2.37% | -2.20% | -3.29% | +42.69% | +84.71% | +213.81% | +6,083.76% | 5.01TCr | |
| +0.12% | -3.44% | -3.46% | +1.20% | +13.78% | +67.99% | +49.40% | -19.22% | - | 4.58TCr | |
| -5.60% | +7.69% | -25.62% | -26.63% | -37.29% | +62.36% | +466.37% | +316.09% | +911.49% | 2.37TCr | |
| -2.65% | -4.86% | -9.97% | -15.42% | -5.93% | -3.02% | -17.01% | -53.55% | - | 2.26TCr | |
| +3.19% | +3.12% | -8.97% | -15.80% | +7.12% | +41.22% | -27.18% | -68.08% | - | 1.78TCr | |
| -2.91% | -10.30% | -18.45% | +14.15% | +6.37% | +47.85% | +186.19% | +135.69% | - | 1.41TCr | |
| -7.00% | -6.69% | -20.12% | +12.77% | -3.54% | -26.94% | +821.86% | +211.83% | +103.25% | 1.31TCr | |
| +0.41% | -2.37% | -15.88% | +4.30% | +11.32% | +40.93% | - | - | - | 1.3TCr | |
| -1.90% | +4.09% | +13.21% | +14.14% | +14.37% | +8.37% | +157.08% | +96.13% | +793.58% | 1.26TCr | |
| -3.00% | +2.68% | +0.99% | +12.69% | -10.07% | +79.46% | +80.40% | +288.78% | - | 1.21TCr | |
| -3.79% | +5.48% | +8.06% | +20.13% | +15.48% | +399.80% | +92.20% | +5.27% | +1,365.97% | 1.08TCr | |
| +5.63% | +14.09% | +27.08% | +13.93% | +75.74% | +81.87% | +173.62% | +1,106.10% | +468.63% | 972.76Cr | |
| -3.80% | -4.34% | -16.47% | -15.92% | -31.76% | - | - | - | - | 842.04Cr | |
| -2.21% | -6.35% | +2.44% | +34.06% | +302.53% | +198.50% | +147.52% | -47.32% | - | 834.74Cr | |
| -0.67% | -8.55% | -24.47% | +11.27% | +24.10% | +116.87% | +123.10% | -3.77% | - | 832.39Cr | |
| -2.02% | -2.83% | -2.34% | +1.47% | +1.70% | +44.08% | +151.10% | - | - | 808.15Cr | |
| -2.13% | -1.17% | -13.33% | -3.16% | +13.55% | +69.55% | +4.03% | +172.30% | - | 756.5Cr | |
| +2.65% | +13.07% | +22.76% | +13.80% | +9.19% | +27.02% | +73.46% | +10.62% | +310.60% | 725.51Cr | |
| -0.96% | -0.17% | +8.60% | +104.53% | +128.69% | +415.27% | +1,981.11% | -60.36% | -58.20% | 650.61Cr | |
| Average | -1.33% | +0.08% | -4.34% | +8.39% | +25.76% | +91.78% | +250.35% | +134.11% | +1,116.22% | 1.58TCr | |
| Weighted average by Cap. | -1.26% | -0.16% | -5.78% | +1.96% | +12.46% | +69.32% | +176.37% | +123.05% | +2,402.66% |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition